Owen T Carmichael1, Rebecca H Neiberg2, Gareth R Dutton3, Kathleen M Hayden4, Edward Horton5, F Xavier Pi-Sunyer6, Karen C Johnson7, Stephen R Rapp8, Adam P Spira9, Mark A Espeland10. 1. Biomedical Imaging Center, Pennington Biomedical Research Center, Baton Rouge, Louisiana. 2. Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina. 3. Department of Medicine, Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama. 4. Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina. 5. Joslin Diabetes Center, Harvard University, Boston, Massachusetts. 6. Division of Endocrinology, Obesity/Nutrition Research Center, Columbia University College of Physicians and Surgeons, New York, NY. 7. Department of Preventive Medicine, The University of Tennessee Health Science Center, Memphis, Tennessee. 8. Department of Psychiatry & Behavioral Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina. 9. Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD. 10. Division of Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Abstract
CONTEXT: The effects of physiological improvements on cognitive function among persons with type 2 diabetes mellitus (T2DM) are not fully understood. OBJECTIVE: To determine whether improvements in physiological markers (body weight, blood sugar control, and physical activity) during intensive lifestyle intervention (ILI) are associated with enhancements in cognitive function in older adults with T2DM. DESIGN: Multisite randomized controlled trial. SETTING: Academic research centers. PATIENTS OR OTHER PARTICIPANTS: Participants were aged 45-76 years, with T2DM. INTERVENTION: The Action for Health in Diabetes (Look AHEAD) study, a randomized, controlled clinical trial of ILI. MAIN OUTCOME MEASURE: Two to 3 cognitive assessments were collected from 1089 participants, the first and last occurring a mean (standard deviation) of 8.6 (1.0) and 11.5 (0.7) years after enrollment. RESULTS: Greater improvement in blood sugar control was associated with better cognitive scores (fasting glucose and Rey Auditory Verbal Learning Test [AVLT]: P = 0.0148; fasting glucose and Digit Symbol Coding (DSC): P = 0.0360; HbA1C and DSC: P = 0.0477); but weight loss had mixed associations with cognitive scores (greater body mass index [BMI] reduction and worse AVLT overall: P = 0.0053; and greater BMI reduction and better DSC scores among those overweight but not obese at baseline: P = 0.010). Associations were strongest among those who were overweight (not obese) at baseline, and among those with a history of cardiovascular disease (CVD) at baseline. CONCLUSIONS: Improvements in glycemic control, but not necessarily weight status, during ILI may be associated with better subsequent cognitive performance. These associations may differ by adiposity and CVD history.
CONTEXT: The effects of physiological improvements on cognitive function among persons with type 2 diabetes mellitus (T2DM) are not fully understood. OBJECTIVE: To determine whether improvements in physiological markers (body weight, blood sugar control, and physical activity) during intensive lifestyle intervention (ILI) are associated with enhancements in cognitive function in older adults with T2DM. DESIGN: Multisite randomized controlled trial. SETTING: Academic research centers. PATIENTS OR OTHER PARTICIPANTS: Participants were aged 45-76 years, with T2DM. INTERVENTION: The Action for Health in Diabetes (Look AHEAD) study, a randomized, controlled clinical trial of ILI. MAIN OUTCOME MEASURE: Two to 3 cognitive assessments were collected from 1089 participants, the first and last occurring a mean (standard deviation) of 8.6 (1.0) and 11.5 (0.7) years after enrollment. RESULTS: Greater improvement in blood sugar control was associated with better cognitive scores (fasting glucose and Rey Auditory Verbal Learning Test [AVLT]: P = 0.0148; fasting glucose and Digit Symbol Coding (DSC): P = 0.0360; HbA1C and DSC: P = 0.0477); but weight loss had mixed associations with cognitive scores (greater body mass index [BMI] reduction and worse AVLT overall: P = 0.0053; and greater BMI reduction and better DSC scores among those overweight but not obese at baseline: P = 0.010). Associations were strongest among those who were overweight (not obese) at baseline, and among those with a history of cardiovascular disease (CVD) at baseline. CONCLUSIONS: Improvements in glycemic control, but not necessarily weight status, during ILI may be associated with better subsequent cognitive performance. These associations may differ by adiposity and CVD history.
Authors: Min Soo Byun; Hyun Jung Kim; Dahyun Yi; Hyo Jung Choi; Hyewon Baek; Jun Ho Lee; Young Min Choe; Bo Kyung Sohn; Jun-Young Lee; Younghwa Lee; Hyunwoong Ko; Yu Kyeong Kim; Yun-Sang Lee; Chul-Ho Sohn; Jong Inn Woo; Dong Young Lee Journal: Neurobiol Aging Date: 2017-07-20 Impact factor: 4.673
Authors: Laura D Baker; Laura L Frank; Karen Foster-Schubert; Pattie S Green; Charles W Wilkinson; Anne McTiernan; Brenna A Cholerton; Stephen R Plymate; Mark A Fishel; G Stennis Watson; Glen E Duncan; Pankaj D Mehta; Suzanne Craft Journal: J Alzheimers Dis Date: 2010 Impact factor: 4.472
Authors: Henry Buchwald; Rhonda Estok; Kyle Fahrbach; Deirdre Banel; Michael D Jensen; Walter J Pories; John P Bantle; Isabella Sledge Journal: Am J Med Date: 2009-03 Impact factor: 4.965
Authors: M Sue Kirkman; Vanessa Jones Briscoe; Nathaniel Clark; Hermes Florez; Linda B Haas; Jeffrey B Halter; Elbert S Huang; Mary T Korytkowski; Medha N Munshi; Peggy Soule Odegard; Richard E Pratley; Carrie S Swift Journal: J Am Geriatr Soc Date: 2012-10-25 Impact factor: 5.562
Authors: Mark A Espeland; José A Luchsinger; Laura D Baker; Rebecca Neiberg; Steven E Kahn; Steven E Arnold; Rena R Wing; George L Blackburn; George Bray; Mary Evans; Helen P Hazuda; Robert W Jeffery; Valerie M Wilson; Jeanne M Clark; Mace Coday; Kathryn Demos-McDermott; John P Foreyt; Frank Greenway; James O Hill; Edward S Horton; John M Jakicic; Karen C Johnson; William C Knowler; Cora E Lewis; David M Nathan; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; Thomas A Wadden; Stephen R Rapp Journal: Neurology Date: 2017-04-26 Impact factor: 9.910
Authors: Mark A Espeland; Kasia Lipska; Michael E Miller; Julia Rushing; Ronald A Cohen; Joseph Verghese; Mary M McDermott; Abby C King; Elsa S Strotmeyer; Steven N Blair; Marco Pahor; Kieran Reid; Jamehl Demons; Stephen B Kritchevsky Journal: J Gerontol A Biol Sci Med Sci Date: 2017-06-01 Impact factor: 6.053